BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 22864932)

  • 1. Triple negative breast cancer is associated with an increased risk of residual invasive carcinoma after lumpectomy.
    Sioshansi S; Ehdaivand S; Cramer C; Lomme MM; Price LL; Wazer DE
    Cancer; 2012 Aug; 118(16):3893-8. PubMed ID: 22864932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of reexcision for positive margins in optimizing local disease control after breast-conserving surgery for cancer.
    Aziz D; Rawlinson E; Narod SA; Sun P; Lickley HL; McCready DR; Holloway CM
    Breast J; 2006; 12(4):331-7. PubMed ID: 16848842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive factors for residual disease in re-excision specimens after breast-conserving surgery.
    Atalay C; Irkkan C
    Breast J; 2012; 18(4):339-44. PubMed ID: 22616572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of margins on ipsilateral breast tumor recurrence after breast conservation therapy for lymph node-negative breast carcinoma.
    Leong C; Boyages J; Jayasinghe UW; Bilous M; Ung O; Chua B; Salisbury E; Wong AY
    Cancer; 2004 May; 100(9):1823-32. PubMed ID: 15112262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defining the clinical target volume for patients with early-stage breast cancer treated with lumpectomy and accelerated partial breast irradiation: a pathologic analysis.
    Vicini FA; Kestin LL; Goldstein NS
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):722-30. PubMed ID: 15465188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient age and positive margins are predictive factors of residual tumor on mastectomy specimen after conservative treatment for breast cancer.
    Voguet L; Hébert T; Levêque J; Acker O; Mesbah H; Marret H; Porée P; Body G
    Breast; 2009 Aug; 18(4):233-7. PubMed ID: 19628389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indication for relumpectomy--a useful scoring system in cases of invasive breast cancer.
    Halevy A; Lavy R; Pappo I; Davidson T; Gold-Deutch R; Jeroukhimov I; Shapira Z; Wassermann I; Sandbank J; Chikman B
    J Surg Oncol; 2012 Mar; 105(4):376-80. PubMed ID: 21780127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy.
    Truong PT; Olivotto IA; Kader HA; Panades M; Speers CH; Berthelet E
    Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1337-47. PubMed ID: 15817335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HER-2 positive breast cancer is associated with an increased risk of positive cavity margins after initial lumpectomy.
    Jia H; Jia W; Yang Y; Li S; Feng H; Liu J; Rao N; Jin L; Wu J; Gu R; Zhu L; Chen K; Deng H; Zeng Y; Liu Q; Song E; Su F
    World J Surg Oncol; 2014 Sep; 12():289. PubMed ID: 25241216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of lobular carcinoma in situ in association with invasive breast cancer on the rate of local recurrence in patients with early-stage breast cancer treated with breast-conserving therapy.
    Jolly S; Kestin LL; Goldstein NS; Vicini FA
    Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):365-71. PubMed ID: 16965988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does the volume of ductal carcinoma in situ impact the positive margin rate in patients undergoing breast conservation for invasive breast cancer?
    Martin-Dunlap TM; Cyr AE; Al Mushawah F; Gao F; Margenthaler JA
    J Surg Res; 2013 Sep; 184(1):228-33. PubMed ID: 23688789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LEA-135 expression: its association with a lower risk of recurrence and increased overall survival of patients with lymph node-positive primary invasive breast cancer.
    Saha B; Zhang N; Naritoku WY; Tsao-Wei DD; Groshen SL; Carlsson G; Larsson L; Gustavsson B; Chaiwun B; Taylor CR; Imam SA
    Anticancer Res; 2004; 24(4):2391-400. PubMed ID: 15330189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of margin status in lumpectomy specimens and residual breast carcinoma.
    Scopa CD; Aroukatos P; Tsamandas AC; Aletra C
    Breast J; 2006; 12(2):150-3. PubMed ID: 16509840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical margins and the risk of local-regional recurrence after mastectomy without radiation therapy.
    Childs SK; Chen YH; Duggan MM; Golshan M; Pochebit S; Wong JS; Bellon JR
    Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):1133-8. PubMed ID: 22543200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association between biological subtype and isolated regional nodal failure after breast-conserving therapy.
    Wo JY; Taghian AG; Nguyen PL; Raad RA; Sreedhara M; Bellon JR; Wong JS; Gadd MA; Smith BL; Harris JR
    Int J Radiat Oncol Biol Phys; 2010 May; 77(1):188-96. PubMed ID: 20171798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of clinical and pathologic variables with lumpectomy surgical margin status after preoperative diagnosis or excisional biopsy of invasive breast cancer.
    Smitt MC; Horst K
    Ann Surg Oncol; 2007 Mar; 14(3):1040-4. PubMed ID: 17203329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ductal carcinoma in situ: size and resection volume predict margin status.
    Melstrom LG; Melstrom KA; Wang EC; Pilewskie M; Winchester DJ
    Am J Clin Oncol; 2010 Oct; 33(5):438-42. PubMed ID: 20023569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accuracy of intraoperative gross examination of surgical margin status in women undergoing partial mastectomy for breast malignancy.
    Balch GC; Mithani SK; Simpson JF; Kelley MC
    Am Surg; 2005 Jan; 71(1):22-7; discussion 27-8. PubMed ID: 15757052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Negative margin status improves local control in conservatively managed breast cancer patients.
    Obedian E; Haffty BG
    Cancer J Sci Am; 2000; 6(1):28-33. PubMed ID: 10696736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ductal carcinoma in situ in core biopsies containing invasive breast cancer: correlation with extensive intraductal component and lumpectomy margins.
    Dzierzanowski M; Melville KA; Barnes PJ; MacIntosh RF; Caines JS; Porter GA
    J Surg Oncol; 2005 May; 90(2):71-6. PubMed ID: 15844190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.